Music to Reduce Use of Smoking in Patients With Schizophrenia
- Conditions
- Smoking, TobaccoSchizophreniaNicotine Dependence
- Interventions
- Behavioral: Music session
- Registration Number
- NCT03190161
- Lead Sponsor
- NYU Langone Health
- Brief Summary
The purpose of this study is to explore the impact of self-selected music listening which targets disrupting the reward process maintaining smoking and additionally attenuating the reward processing deficits associated with schizophrenia. Five participants with schizophrenia/schizoaffective disorder who smoke/nicotine will participate in an individual session of self-selected music listening for a half an hour.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2
- clinician verification diagnosis of Schizophrenia or Schizoaffective Disorder
- smoked at least 10 cigarettes per day for the past month
- score of 4 or more on the Fagerstrom Test for Nicotine Dependence73
- psychiatric stability (e.g., no psychiatric hospitalizations within the last year, no expectation for medication change during study participation, no active suicidal ideation, no symptoms that interfere with ability to participate in study activities)
- the capacity to participate in the informed consent process
- being medically unstable (e.g., medical condition that requires frequent medical appointments or hospitalizations and interferes with ability to participate in study activities)
- report active substance abuse or testing positive drug or alcohol use
- taking bupropion, varenicline, nicotine replacement products and/or involved in any other smoking cessation treatment
- participating in any treatment or activity that includes music as a focus
- having a seizure disorder, other neurological illnesses, or a family history of seizures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Schizophrenia Patients Music session Clinician verification diagnosis of Schizophrenia or Schizoaffective Disorder
- Primary Outcome Measures
Name Time Method Questionnaire of Smoking Urges-Brief (QSU-B) Post Music Session 1 Day Measures Cravings Post Music Session
Snaith-Hamilton Pleasure Scale (SHAPS) 1 Day Measures Pleasure Pre Music Session
Pleasure Rating Scale (PRS) Post Music Session 1 Day Measures Pleasure Post Music Session
Minnesota Nicotine Withdrawal Scale (MNWS) Post Music Session 1 Day Measures Withdrawal Post Music Session
Questionnaire of Smoking Urges-Brief (QSU-B) 1 Day Measures Cravings Pre Music Session
Snaith-Hamilton Pleasure Scale (SHAPS) Post Music Session 1 Day Measures Pleasure Post Music Session
Pleasure Rating Scale (PRS) 1 Day Measures Pleasure Pre Music Session
Minnesota Nicotine Withdrawal Scale (MNWS) 1 Day Measures Withdrawal Pre Music Session and Post Music Session
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
New York University School of Medicine
🇺🇸New York, New York, United States